- Study Confirms Minorities Face Higher Odds of COVID-19: Study
- Lockdown Could Worsen Hearing Woes for U.S. Seniors
- Women Get Worse Care for Heart Attack
- Global Death Toll From COVID-19 Passes One Million
- Health Highlights: Sept. 29, 2020
- Preparing for Flooding During Hurricane Season
- How You Can Help Prevent Suicide During the COVID-19 Pandemic
- ‘Silent’ COVID-19 Produces as Much Virus as in Patients With Symptoms: Study
- Immune System Clues to Why COVID Is Easier on Kids
- Is Shock Therapy Making a Comeback Against Bipolar Disorder?
Clinical Trials Update: Jan. 28, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Active H1N1 Virus
This study seeks people with active H1N1 virus. To qualify, you must have had two or more of these symptoms — fever, cough, sore throat or rhinitis — for 72 hours or less.
The research site is in Tuscaloosa, Ala.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/flu.aspx.
—–
Restless Legs Syndrome (RLS)
This study of an investigational drug is for people with restless legs syndrome. Participants will receive free study-related exams and medication.
The research site is in Dublin, Ohio.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/restless_legs_syndrome.aspx.
—–
Diabetic Foot Ulcers
This study will evaluate the safety and effectiveness of a device called dermaPACE to help treat diabetic foot ulcers.
The research site is in Dallas, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
